XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
REVENUE    
Sales $ 218,415 $ 210,279
Cost of goods sold 178,309 188,071
Gross profit 40,106 22,208
OPERATING EXPENSES    
General and administrative expenses, includes $274,315 and $451,987 in stock-based compensation, respectively 4,368,843 4,624,158
Research and development, includes $62,633 and $149,288 in stock-based compensation, respectively 1,387,541 1,428,382
Sales and marketing, includes $2,503 and $0 in stock-based compensation, respectively 65,617 86,599
Total operating expenses 5,822,001 6,139,139
NET LOSS FROM OPERATIONS (5,781,895) (6,116,931)
OTHER EXPENSE    
Interest expense (198,492) (15,210)
Interest income 9,074 14,040
Other income 58,960
Amortization of debt discount (13,393)
Total other expense (202,811) 57,790
Net loss before income taxes (5,984,706) (6,059,141)
Income tax provision
NET LOSS $ (5,984,706) $ (6,059,141)
Net loss per share - basic and diluted (in Dollars per share) $ (1.31) $ (6.8)
Weighted average number of shares outstanding during the period - basic and diluted (in Shares) 4,562,873 891,614